IPHA
Innate Pharma
IPHA
IPHA
12 hedge funds and large institutions have $1.89M invested in Innate Pharma in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
$32K |
| 2 |
Morgan Stanley
New York
|
$114K |
| 3 |
Optiver Holding
Amsterdam,
Netherlands
|
$371K |
| 4 |
UBS Group
Zurich,
Switzerland
|
$9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $965K | -$29.3K | -14,630 | -3% |
|
|
2
Optiver Holding
Amsterdam,
Netherlands
| $371K | +$6.74K | +3,366 | +2% |
|
3
Bank of America
Charlotte,
North Carolina
| $330K | -$20.9K | -10,451 | -6% |
|
|
4
Morgan Stanley
New York
| $114K | +$20.6K | +10,254 | +22% |
|
5
Two Sigma Investments
New York
| $38K | -$13.1K | -6,500 | -26% |
|
|
6
Balyasny Asset Management
Chicago,
Illinois
| $32K | +$32K | +16,094 | New |
|
7
Millennium Management
New York
| $29K | -$4.4K | -2,222 | -13% |
|
|
8
UBS Group
Zurich,
Switzerland
| $9K | +$3.1K | +1,549 | +52% |
|
|
SPIA
9
Steward Partners Investment Advisory
New York
| $1K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | -$7K | -2,600 | Closed |
|
|
CS
11
Credit Suisse
Zurich,
Switzerland
| – | -$5K | -1,981 | Closed |
|
12
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$2K | -905 | Closed |
|